已收盘 12-19 16:00:00 美东时间
-0.390
-1.48%
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
11-21 15:50
今日重点评级关注:富国银行:维持Annexon"超配"评级,目标价从14美元升至27美元;瑞穗:上调Relmada Therapeutics评级至"跑赢大市",目标价从1美元升至10美元
11-20 10:28
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
11-19 11:01
DA Davidson analyst Peter Heckmann maintains i3 Verticals (NASDAQ:IIIV) with a Buy and maintains $39 price target.
11-19 04:02
Earnings Call Insights: i3 Verticals, Inc. (IIIV) Q4 2025 Management View CEO Gregory Daily reflected on the company's transformation, stating that "divesting our Merchant Services and our health care...
11-18 23:39
i3 Verticals shares are trading lower. The company reported Q4 financial result...
11-18 22:01
I3 Verticals ( ($IIIV) ) has provided an announcement. On November 12, 2025, Bu...
11-18 06:48
i3 Verticals (NASDAQ:IIIV) is looking for FY2026 Adj EPS of $1.06-$1.16 vs $1.05 analyst estimate. sees sales of $217.000 million-$232.000 million vs $220.816 million analyst estimate.
11-18 06:34
Companies Reporting Before The Bell • So-Young Intl (NASDAQ:SY) is projected to...
11-17 19:11
i3 Verticals (NASDAQ:IIIV) is gearing up to announce its quarterly earnings on ...
11-14 22:02